Periprocedural Anticoagulation Management of Patients receiving Warfarin in Qatar: A Prospective Cohort Study
<p dir="ltr">Background: The use of anticoagulant bridging remains controversial. This study was conducted to evaluate our warfarin periprocedural management in Qatar and investigate the associated clinical outcomes with such management. Methods: A prospective cohort study was design...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | , , , , , , , , , |
| منشور في: |
2021
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
| _version_ | 1864513543640973312 |
|---|---|
| author | Islam Eljilany (14151588) |
| author2 | Mohamed Elarref (17316937) Nabil Shallik (15900256) Abdel-Naser Elzouki (9376853) AbdulMoqeeth Mohammed (14151621) Bassam Shoman (17316940) Sami Ibrahim (17316943) Cornelia Carr (17316946) Daoud Al-Badriyeh (832403) Larisa H. Cavallari (7943018) Hazem Elewa (3592601) |
| author2_role | author author author author author author author author author author |
| author_facet | Islam Eljilany (14151588) Mohamed Elarref (17316937) Nabil Shallik (15900256) Abdel-Naser Elzouki (9376853) AbdulMoqeeth Mohammed (14151621) Bassam Shoman (17316940) Sami Ibrahim (17316943) Cornelia Carr (17316946) Daoud Al-Badriyeh (832403) Larisa H. Cavallari (7943018) Hazem Elewa (3592601) |
| author_role | author |
| dc.creator.none.fl_str_mv | Islam Eljilany (14151588) Mohamed Elarref (17316937) Nabil Shallik (15900256) Abdel-Naser Elzouki (9376853) AbdulMoqeeth Mohammed (14151621) Bassam Shoman (17316940) Sami Ibrahim (17316943) Cornelia Carr (17316946) Daoud Al-Badriyeh (832403) Larisa H. Cavallari (7943018) Hazem Elewa (3592601) |
| dc.date.none.fl_str_mv | 2021-06-01T00:00:00Z |
| dc.identifier.none.fl_str_mv | 10.1016/j.cpcardiol.2021.100816 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/journal_contribution/Periprocedural_Anticoagulation_Management_of_Patients_receiving_Warfarin_in_Qatar_A_Prospective_Cohort_Study/24474610 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Biomedical and clinical sciences Cardiovascular medicine and haematology Pharmacology and pharmaceutical sciences Periprocedural Anticoagulation Patients Warfarin Qatar Cohort Study |
| dc.title.none.fl_str_mv | Periprocedural Anticoagulation Management of Patients receiving Warfarin in Qatar: A Prospective Cohort Study |
| dc.type.none.fl_str_mv | Text Journal contribution info:eu-repo/semantics/publishedVersion text contribution to journal |
| description | <p dir="ltr">Background: The use of anticoagulant bridging remains controversial. This study was conducted to evaluate our warfarin periprocedural management in Qatar and investigate the associated clinical outcomes with such management. Methods: A prospective cohort study was designed to describe the periprocedural clinical practice in warfarin patients in Qatar and to compare clinical safety and efficacy outcomes between anticoagulant bridging and nonbridging. Results: 103 patients were recruited. Bridging occurred in 82% of the participants. No thromboembolic events were observed, while 39.1% of patients experienced bleeding events during the study period. The incidence of overall bleeding and major bleeding were numerically higher for bridging group compared to nonbridging but did not reach statistical significance ([30.6% vs 22.2%, P = 0.478] and [12.9% vs 5.6%, P = 0.375], respectively). Conclusion: Warfarin interruption and bridging are overwhelmingly used in warfarin-treated patients in Qatar. While bridging was numerically associated with increased bleeding events, there is no statistical difference in reported clinical events between bridging and nonbridging strategies.</p><h2>Other Information</h2><p dir="ltr">Published in: Current Problems in Cardiology<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1016/j.cpcardiol.2021.100816" target="_blank">https://dx.doi.org/10.1016/j.cpcardiol.2021.100816</a></p> |
| eu_rights_str_mv | openAccess |
| id | Manara2_34bbac8e9669ccc5bab16e0b43476be8 |
| identifier_str_mv | 10.1016/j.cpcardiol.2021.100816 |
| network_acronym_str | Manara2 |
| network_name_str | Manara2 |
| oai_identifier_str | oai:figshare.com:article/24474610 |
| publishDate | 2021 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | Periprocedural Anticoagulation Management of Patients receiving Warfarin in Qatar: A Prospective Cohort StudyIslam Eljilany (14151588)Mohamed Elarref (17316937)Nabil Shallik (15900256)Abdel-Naser Elzouki (9376853)AbdulMoqeeth Mohammed (14151621)Bassam Shoman (17316940)Sami Ibrahim (17316943)Cornelia Carr (17316946)Daoud Al-Badriyeh (832403)Larisa H. Cavallari (7943018)Hazem Elewa (3592601)Biomedical and clinical sciencesCardiovascular medicine and haematologyPharmacology and pharmaceutical sciencesPeriproceduralAnticoagulationPatientsWarfarinQatarCohort Study<p dir="ltr">Background: The use of anticoagulant bridging remains controversial. This study was conducted to evaluate our warfarin periprocedural management in Qatar and investigate the associated clinical outcomes with such management. Methods: A prospective cohort study was designed to describe the periprocedural clinical practice in warfarin patients in Qatar and to compare clinical safety and efficacy outcomes between anticoagulant bridging and nonbridging. Results: 103 patients were recruited. Bridging occurred in 82% of the participants. No thromboembolic events were observed, while 39.1% of patients experienced bleeding events during the study period. The incidence of overall bleeding and major bleeding were numerically higher for bridging group compared to nonbridging but did not reach statistical significance ([30.6% vs 22.2%, P = 0.478] and [12.9% vs 5.6%, P = 0.375], respectively). Conclusion: Warfarin interruption and bridging are overwhelmingly used in warfarin-treated patients in Qatar. While bridging was numerically associated with increased bleeding events, there is no statistical difference in reported clinical events between bridging and nonbridging strategies.</p><h2>Other Information</h2><p dir="ltr">Published in: Current Problems in Cardiology<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1016/j.cpcardiol.2021.100816" target="_blank">https://dx.doi.org/10.1016/j.cpcardiol.2021.100816</a></p>2021-06-01T00:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1016/j.cpcardiol.2021.100816https://figshare.com/articles/journal_contribution/Periprocedural_Anticoagulation_Management_of_Patients_receiving_Warfarin_in_Qatar_A_Prospective_Cohort_Study/24474610CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/244746102021-06-01T00:00:00Z |
| spellingShingle | Periprocedural Anticoagulation Management of Patients receiving Warfarin in Qatar: A Prospective Cohort Study Islam Eljilany (14151588) Biomedical and clinical sciences Cardiovascular medicine and haematology Pharmacology and pharmaceutical sciences Periprocedural Anticoagulation Patients Warfarin Qatar Cohort Study |
| status_str | publishedVersion |
| title | Periprocedural Anticoagulation Management of Patients receiving Warfarin in Qatar: A Prospective Cohort Study |
| title_full | Periprocedural Anticoagulation Management of Patients receiving Warfarin in Qatar: A Prospective Cohort Study |
| title_fullStr | Periprocedural Anticoagulation Management of Patients receiving Warfarin in Qatar: A Prospective Cohort Study |
| title_full_unstemmed | Periprocedural Anticoagulation Management of Patients receiving Warfarin in Qatar: A Prospective Cohort Study |
| title_short | Periprocedural Anticoagulation Management of Patients receiving Warfarin in Qatar: A Prospective Cohort Study |
| title_sort | Periprocedural Anticoagulation Management of Patients receiving Warfarin in Qatar: A Prospective Cohort Study |
| topic | Biomedical and clinical sciences Cardiovascular medicine and haematology Pharmacology and pharmaceutical sciences Periprocedural Anticoagulation Patients Warfarin Qatar Cohort Study |